![]() Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | ![]() Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | ||
Founding Date | Founding Date 1996 | Founding Date 2006 | Founding Date 1998 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US |
Employees | Employees 2152% increase | Employees 21316% decrease | Employees 1091% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $94.6m (FY, 2023) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $76.5m (FY, 2023) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit N/A | Gross profit $114.4m (FY, 2018) |
Net income | Net income N/A | Net income ($13.3m) (FY, 2023) | Net income ($147.7m) (FY, 2018) |
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View companyArray BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company